
GC73885
PLK1/BRD4-IN-3
Also known as 4-[[(7S)-8-cyclopentyl-5,7-dimethyl-6-oxo-7H-pteridin-2-yl]amino]-3-cyclopentyloxy-N-(1-methylpiperidin-4-yl)benzamide
PLK1/BRD4-IN-3 (Compound 21) is a selective dual inhibitor for bromodomain 4 (BRD4) and polo-like kinase 1 (PLK1)
ChemicalCAS2251709-91-6MW561.72FormulaC31H43N7O3
- CAS number
- 2251709-91-6
- Molecular weight
- 561.72
- Formula
- C31H43N7O3
- Solubility
- DMSO : 16·67 mg/mL (29·68 mM; ultrasonic and warming and heat to 60°C)
- InChIKey
- HTPNGOWITIWAHM-FQEVSTJZSA-N
- Catalogue number
- GC73885
- Brand
- GLPBIO
Computed properties PubChem CID 145976646 · XLogP 4.5 · TPSA 103 Ų · H-bond donors 2
- XLogP
- 4.5
- TPSA
- 103 Ų
- H-bond donors
- 2
- H-bond acceptors
- 8
- Rotatable bonds
- 7
- Heavy atoms
- 41
SMILES C[C@H]1C(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC6CCCC6)C
Computed descriptors from PubChem (CID 145976646), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il